Special Issue "Selected Papers from Canadian Diarrhetic Shellfish Poisoning Symposium"

Quicklinks

A special issue of Marine Drugs (ISSN 1660-3397).

Deadline for manuscript submissions: closed (30 June 2013)

Special Issue Editors

Guest Editor
Dr. Catherine Elliott
Environmental Health Services, BC Centre for Disease Control, 655 West 12th Avenue, Vancouver, British Columbia, V5Z 4R4, Canada
Website: http://www.bccdc.ca/util/about/UBCCDC/People/Faculty/CatherineElliott.htm
E-Mail: Catherine.Elliott@bccdc.ca
Phone: +1 604 707 2462
Fax: +1 604 707 2441

Guest Editor
Mr. Lorraine McIntyre
Environmental Health Services, BC Centre for Disease Control, 655 West 12th Avenue, Vancouver, British Columbia, V5Z 4R4, Canada
E-Mail: Lorraine.McIntyre@bccdc.ca
Phone: +1 604 707 2458
Fax: +1 604 707 2441

Special Issue Information

Dear Colleagues,

Industry, government regulators and public health stakeholders are challenged by emerging issues caused by harmful algal blooms (HABs). In 2011, the Pacific Northwest was challenged with Diarrhetic Shellfish Poisoning (DSP). These HABs led to illnesses in the United States (US) and Canada.

To facilitate a deeper understanding of DSP as an emergent issue, a symposium was held in North Vancouver, British Columbia (BC) Canada on November 27, 2012. Invited speakers addressed a broad spectrum of topics: HABs and human health, government agency programs for risk assessment and regulation, phytoplankton monitoring and research of HABs, outbreak summaries from BC and Washington, in addition to ways in which we can improve and foster communication between stakeholders. More information about these presentations can be found at http://www.bccdc.ca/foodhealth/fish/DSP_Symposium.htm

This special issue is based on presentations and research initiatives presented at the November 2012 DSP symposium. One of the challenges faced by industry is how to predict when HABs may impact harvesting. Tests to assay for DSP (okadaic acid and Dinophysis toxins) are currently done by liquid chromatography-mass spectrometry (LC-MS/MS) in Nova Scotia, located on the east coast of Canada. In one paper, colleagues from the US will describe how two other assays, ELISA and an inhibition assay, compare to LC-MS/MS methods. Other collaborations and potential research initiatives will be explored, and the Canadian outbreak will be described.

Dr. Catherine Elliot
Mr. Lorraine McIntyre
Guest Editors

Submission

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed Open Access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs).

Keywords

  • diarrhetic shellfish poisoning (DSP)
  • shellfish poisoning
  • human intoxication
  • harmful algal bloom (HAB)
  • inhibition assay
  • ELISA
  • public health

Published Papers (5 papers)

Mar. Drugs 2013, 11(11), 4144-4157; doi:10.3390/md11114144
Received: 30 July 2013; in revised form: 3 October 2013 / Accepted: 15 October 2013 / Published: 29 October 2013
Show/Hide Abstract | Download PDF Full-text (529 KB) | View HTML Full-text | Download XML Full-text

Mar. Drugs 2013, 11(10), 3823-3845; doi:10.3390/md11103823
Received: 10 July 2013; in revised form: 19 August 2013 / Accepted: 23 August 2013 / Published: 11 October 2013
Show/Hide Abstract | Download PDF Full-text (1710 KB) | View HTML Full-text | Download XML Full-text

Mar. Drugs 2013, 11(10), 3718-3734; doi:10.3390/md11103718
Received: 19 August 2013; in revised form: 7 September 2013 / Accepted: 10 September 2013 / Published: 30 September 2013
Show/Hide Abstract | Download PDF Full-text (871 KB) | View HTML Full-text | Download XML Full-text

Mar. Drugs 2013, 11(8), 2964-2981; doi:10.3390/md11082964
Received: 16 July 2013; in revised form: 2 August 2013 / Accepted: 5 August 2013 / Published: 16 August 2013
Show/Hide Abstract | Download PDF Full-text (2022 KB) | View HTML Full-text | Download XML Full-text

Mar. Drugs 2013, 11(5), 1669-1676; doi:10.3390/md11051669
Received: 12 March 2013; in revised form: 5 April 2013 / Accepted: 19 April 2013 / Published: 21 May 2013
Show/Hide Abstract | Download PDF Full-text (660 KB) | View HTML Full-text | Download XML Full-text

Last update: 5 March 2013

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert